HR 1142 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
Summary
This bill amends the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines for Medicare Part B and D drugs, with a target of achieving 90 percent patient adherence. The guidelines must incorporate artificial intelligence and machine learning technologies to support adherence. The Secretary is directed to promote the use of generic and biosimilar drugs to the maximum extent practicable through these guidelines.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
Money behind the sponsor
Top reported contributors to David Schweikert’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $273,533
- CEO $16,700
- STENSON TAMADDON $13,700
- OPTIMA FINANCIAL GROUP $13,600
- BRODIE GENERATIONAL CAPITAL PARTNERS $13,200
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for David Schweikert → · Outside spending →
Actions (2)
- Feb 7, 2025 Referred to the House Committee on Energy and Commerce. · house
- Feb 7, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
February 7, 2025
Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. ESTABLISHMENT OF DRUG ADHERENCE GUIDELINES.
Title XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by inserting after section 1711 (42 U.S.C. 300u-16) the following:
“SEC. 1712. ESTABLISHMENT OF DRUG ADHERENCE GUIDELINES.
“(a) In General.—The Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.
“(b) Contents.—In establishing the guidelines under subsection
(a), the Secretary shall—
“(1) incorporate artificial intelligence and machine learning technologies; and
“(2) to the maximum extent practicable, promote the use of generic and biosimilar drugs.
“(c) Definitions.—In this section:
“(1) Medicare part b drug.—The term ‘Medicare part B drug’ means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.).
“(2) Medicare part d drug.—The term ‘Medicare part D drug’ means a covered part D drug (as defined in section 1860D- 2(e) of the Social Security Act (42 U.S.C. 1395w-102(e))).”. <all>
Comments